Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
24.46 USD | -9.27% | -9.74% | -25.95% |
05-10 | UBS Trims Price Target on Evolent Health to $44 From $46, Keeps Buy Rating | MT |
05-09 | Evolent Health Q1 Adjusted Earnings, Revenue Rise; Q2 Revenue Guidance Set, 2024 Revenue Outlook Increased | MT |
- Stock Market
- Equities
- EVH Stock
- News Evolent Health, Inc.
- Trading Ideas